DASI Simulations
About DASI Simulations
DASI Simulations is a healthcare AI company that specializes in advanced individualized computational predictive modeling for structural heart disease. Their technology leverages artificial intelligence and computer vision to transform routine imaging data, such as CT angiograms, into dynamic, patient-specific 3D simulations. This allows physicians and heart surgeons to visualize and predict the interaction between various heart implants and devices and a patient’s unique anatomy prior to procedures like Transcatheter Aortic Valve Implantation (TAVI).
The company’s flagship products, Precision TAVI™ and DASI Dimensions™, are FDA-cleared and designed to enhance pre-procedural planning by providing real-time, predictive insights into the efficacy of different treatment options. This approach aims to reduce manual planning time, minimize risks, anticipate potential complications (such as pacemaker risk or calcium shift), and optimize device selection and placement. By offering personalized and device-agnostic insights, DASI Simulations empowers clinicians to make more informed decisions, leading to improved patient outcomes and reduced costs associated with structural heart disease surgeries.
DASI Simulations is committed to advancing precision medicine in cardiovascular care, with a focus on lifelong planning and complication reduction for patients with heart valve disease. Their platform supports simulating procedures, predicting outcomes, and personalizing treatment for patients with structural heart disease, thereby redefining the standard of care.
Focus Areas
Business Intelligence
| Key Investors | Cleveland Clinic, NIH Small Business Innovation Research, Georgia Tech VentureLab, Cedars Sinai Health Ventures, K2X, TiE Women, Accelerating Angels |
| Partnerships | Cleveland Clinic, Medtronic |
| Technology | AI-powered medical platform, computer vision, computational predictive modeling, physics-based AI, cloud-based platform (AWS), digital twin software, converts CT scans into 4D predictive environments, mobile application, web browsers |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
DASI Simulations offers a paradigm shift in pre-procedural planning for structural heart interventions, particularly TAVR. Physicians can leverage their FDA-cleared and CMS-reimbursable PrecisionTAVIu2122 and DASI Dimensionsu2122 products to gain real-time, predictive insights into device-anatomy interactions. This technology moves beyond basic manual measurements, enabling interactive visualization of treatment scenarios and predicting potential complications, thereby enhancing decision-making confidence and optimizing patient outcomes. The device-agnostic nature of their platform ensures unbiased recommendations, focusing solely on patient-specific needs and long-term management. Integration is designed to be seamless, converting routine CT angiograms into dynamic 3D simulations accessible via cloud portals and mobile applications, supported by a human-in-the-loop quality check for accuracy. This allows for more precise valve selection, sizing, and positioning, ultimately reducing risks and streamlining clinical workflows.
DASI Simulations integrates effortlessly into existing clinical workflows. Physicians upload patient CT angiograms to a secure cloud server, which then generates a personalized computational model of the heart. The interactive simulation results inform decisions about valve type, size, and position, and can guide TAVR procedures in real-time. The platform is accessible via cloud portals and mobile applications, and they are actively co-developing next-generation AI predictive modeling solutions for intraprocedural TAVR guidance with partners like Cleveland Clinic.
Reviews & Opinions
Videos
News, demos, and interviews about DASI Simulations.
Videos load interactively. If none appear, search YouTube for DASI Simulations →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]